Literature DB >> 16026333

The intracellular domain of p75NTR as a determinant of cellular reducing potential and response to oxidant stress.

Yulia Y Tyurina1, Karen D Nylander, Zeljka Korade Mirnics, Carmel Portugal, Chaohua Yan, Clara Zaccaro, H Uri Saragovi, Valerian E Kagan, Nina F Schor.   

Abstract

The low-affinity neurotrophin receptor, p75NTR, has been found to be pro- or anti-apoptotic depending upon the cell in which it is expressed. Reactive oxygen species play a major role in apoptosis induction and enactment. Using two polyclonal PC12 populations that, respectively, do or do not express p75NTR, this paper demonstrates that p75NTR expression confers resistance to oxidant stress upon PC12 cells maintained in serum-containing medium. The effect of p75NTR on cell survival is mimicked in p75-negative cells by expression of constructs that produce the p75NTR intracellular domain (ICD) or p75NTR with the extracellular domain deleted (DeltaECD), suggesting that binding of an extracellular ligand to p75NTR is not required. Our studies further document that the differential sensitivity to oxidant stress is serum-dependent and associated with differential oxidation of glutathione between p75-positive and p75-negative cells. These results suggest that the role of p75NTR in determining the consequences and treatment of age-related disorders and conditions in which reactive oxygen species are involved may require neither the extracellular receptor domain nor, by inference, the cognate extracellular ligands of this neurotrophin receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026333     DOI: 10.1111/j.1474-9726.2005.00160.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  16 in total

1.  p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.

Authors:  Veena R Ganeshan; Nina F Schor
Journal:  Cancer Chemother Pharmacol       Date:  2013-11-20       Impact factor: 3.333

Review 2.  The child is father to the man: developmental roles for proteins of importance for neurodegenerative disease.

Authors:  Danny Rogers; Nina F Schor
Journal:  Ann Neurol       Date:  2010-02       Impact factor: 10.422

3.  Necdin and neurotrophin receptors: interactors of relevance for neuronal resistance to oxidant stress.

Authors:  Christopher A Ingraham; Larissa Wertalik; Nina F Schor
Journal:  Pediatr Res       Date:  2011-04       Impact factor: 3.756

Review 4.  Pharmacologic management of high-risk neuroblastoma in children.

Authors:  Veena R Ganeshan; Nina F Schor
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

5.  A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress.

Authors:  Bradley R Kraemer; John P Snow; Peter Vollbrecht; Amrita Pathak; William M Valentine; Ariel Y Deutch; Bruce D Carter
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

6.  Role of tyrosine phosphorylation in the antioxidant effects of the p75 neurotrophin receptor.

Authors:  Tong Zhang; Zhiping Mi; Nina F Schor
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543

7.  p75NTR: an enhancer of fenretinide toxicity in neuroblastoma.

Authors:  Veena Ganeshan; John Ashton; Nina F Schor
Journal:  Cancer Chemother Pharmacol       Date:  2013-01-13       Impact factor: 3.333

8.  p75NTR-dependent modulation of cellular handling of reactive oxygen species.

Authors:  Zhiping Mi; Danny A Rogers; Zeljka Korade Mirnics; Nina Felice Schor
Journal:  J Neurochem       Date:  2009-04-30       Impact factor: 5.372

9.  Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy.

Authors:  Danny Rogers; Karen D Nylander; Zhiping Mi; Tong Hu; Nina F Schor
Journal:  Cancer Chemother Pharmacol       Date:  2008-03-13       Impact factor: 3.333

10.  Necdin and TrkA contribute to modulation by p75NTR of resistance to oxidant stress.

Authors:  Christopher A Ingraham; Nina F Schor
Journal:  Exp Cell Res       Date:  2009-10-08       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.